AMGN vs CACC · P/E 24, rev $10.05B vs P/E 23, rev $1.17B
Amgen Inc (AMGN) versus Credit Acceptance Corporation (CACC) — a side-by-side from cached financials, not a winner call.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
Credit Acceptance Corporation (CACC) is a credit services company listed on US.
Latest reported AMGN revenue for 2026-06-30 was $10.05B. Net income was $2.38B. Revenue was up 16.7% from 2026-03-31 to 2026-06-30. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
Latest reported CACC revenue for 2026-06-30 was $1.17B. Net income was $271.7M. CACC currently screens at market cap $6.16B and trailing P/E 22.6.
AMGN currently screens at market cap $188.67B and trailing P/E 24.3. CACC currently screens at market cap $6.16B and trailing P/E 22.6.
Not investment advice. Open the AMGN and CACC stock pages for the full models.
Not investment advice.